we are pleased to announce the launch of this year’s canadian cancer society awards for excellence in cancer research, to recognize individuals who have made, and are making, valuable contributions to cancer research and cancer control in canada. recipients are leaders in their fields who exemplify excellence in science and outstanding service to the scientific community.

the nomination deadline is may 29, 2019. guidelines are available on our website.

information on previous award winners is available here.

the fy19 defense appropriation provides $100 million (m) to the department of defense prostate cancer research program (pcrp) to support innovative, high-impact prostate cancer research.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate, manages the defense health program research, development, test, and evaluation appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

fy19 pcrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website.

the mission of the pcrp is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of service members, veterans, and all the men and their families who are experiencing the impact of the disease.  applications submitted to the fy19 pcrp must address one or more of the program’s overarching challenges:

• ·         improve the quality of life for survivors of prostate cancer
• ·         develop treatments that improve outcomes for men with lethal prostate cancer
• ·         reduce lethal prostate cancer in african americans, veterans, and other high-risk populations
• ·         define the biology of lethal prostate cancer to reduce death

https://cdmrp.army.mil/funding/pcrp

early investigator research award

by march 31, 2020, postdoctoral principal investigators (pis):

• ·         must possess a doctoral degree (or equivalent)
• ·         have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training)
• ·         supports research opportunities focused on prostate cancer for individuals in the early stages of their careers.
• ·         pis must have a designated mentor who is an experienced prostate cancer researcher.
• ·         applications from pis who demonstrate a commitment to pursuing a career focused in prostate cancer health disparity research are highly encouraged.
• ·         must address at least one of the fy19 pcrp overarching challenges.
• ·         maximum of $200,000 for direct costs (plus indirect costs).
• ·         maximum period of performance is 2 years.

physician research award

at the time of application submission, the pi must be either:

• ·      in the last year of an accredited graduate medical education program, either as a resident fellow:
• ·      or
• ·      within 5 years of having initiated a faculty appointment (including instructor positions)
• ·      supports a mentored research experience to prepare physicians with clinical duties for careers in prostate cancer research.
• ·      pis must demonstrate a commitment to a career at the forefront of prostate cancer research and clinical practice.
• ·      pis must have a designated mentor with an established research program in prostate cancer.
• ·      must address at least one of the fy19 pcrp overarching challenges.
• ·     maximum funding of $750k for direct costs (plus indirect costs).
• ·      maximum period of performance is 4 years.

idea development award

established investigators:  independent investigators at all levels

or

new investigators:  investigators that meet the following criteria at the application submission deadline date:

• ·      have the freedom to pursue individual aims without formal mentorship
• ·      have not previously received a pcrp health disparity research award and/or idea development award
• ·      have either completed at least 3 years of postdoctoral training or fellowship or are within 10 years after completion of terminal degree (excluding residency or family leave)
• ·      preproposal is required; application submission is by invitation only.
• ·      supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research and have the potential to make an important contribution to one or more of the fy19 pcrp overarching challenges.
• ·      emphasis is equally placed on innovation and impact.
• ·      preliminary data are encouraged, but not required.
• ·      clinical trials are not allowed.
• ·      must address at least one of the fy19 pcrp overarching challenges.
• ·      each pi may submit only one application.
• ·      new investigator option supports applicants early in their faculty appointments or in the process of developing independent research careers
• ·      established investigators:
• ·      maximum funding of $750,000 for direct costs (plus indirect costs).
• ·      new investigators:
• ·      maximum funding of $600,000 for direct costs (plus indirect costs)
• ·      maximum period of performance is 3 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the pcrp or other cdmrp-administered programs, please visit the cdmrp website(https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507 
help@ebrap.org

the fy19 defense appropriation provides $3 million (m) to the department of defense bone marrow failure research program (bmfrp) to support scientifically meritorious research focused on bmf diseases.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

fy19 bmfrp program announcement and general application instructions for the following award mechanism are posted on the grants.gov website.

https://cdmrp.army.mil/funding/bmfrp

idea development award – preproposal due date june 6, 2019

established investigators: 

• independent investigators at or above the level of assistant professor (or equivalent) and 10 years or more from first faculty appointment (or equivalent) at the time of the application submission deadline are eligible.

early career investigators:

• investigators at the level of assistant professor (or equivalent) and less than 10 years from his/her first faculty appointment (or equivalent) at the time of application submission deadline are eligible.

• pre-application is required; full application submission is by invitation only.
• supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move toward the vision to understand and cure bone marrow failure (bmf) diseases.
• strong bmf research team.
• may include relevant preliminary data.
• the maximum allowable funding for the entire period of performance is $325,000 in direct costs (plus indirect costs).

• clinical trials will not be supported.

• the maximum period of performance is 2 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the bmfrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk 
301-682-5507 
help@ebrap.org

canada’s current skills development infrastructure offers few training opportunities for mid-career workers. yet this group will undoubtedly be impacted by labour market disruptions that will displace existing jobs, create new jobs that demand different skills, and change the trajectory of many canadians’ working lives. in many sectors and regions, labour market disruption is already occurring, leaving many canadians in precarious economic positions without the support they need to build new skills, increase their capacity, and navigate an increasingly complex world of work.  

the fsc-ccf is seeking proposals for innovative projects that help fill gaps in training opportunities for mid-career workers. the centre will work with successful project proponents to support efforts to generate forward looking, responsive, and evidence-informed solutions to better meet the needs of mid-career workers facing challenges in the labour market.

• download the guidelines pdf (200 kb)
• download the application instructions pdf (197 kb)

canada’s current skills development infrastructure offers few training opportunities for mid-career workers. yet this group will undoubtedly be impacted by labour market disruptions that will displace existing jobs, create new jobs that demand different skills, and change the trajectory of many canadians’ working lives. in many sectors and regions, labour market disruption is already occurring, leaving many canadians in precarious economic positions without the support they need to build new skills, increase their capacity, and navigate an increasingly complex world of work.  

the fsc-ccf is seeking proposals for innovative projects that help fill gaps in training opportunities for mid-career workers. the centre will work with successful project proponents to support efforts to generate forward looking, responsive, and evidence-informed solutions to better meet the needs of mid-career workers facing challenges in the labour market.

• download the guidelines pdf (200 kb)
• download the application instructions pdf (197 kb)

the responsive grants program enables the law foundation of ontario to fund ideas generated by nonprofit community groups to improve access to justice. the responsive grants program includes one round of major grants (two streams: up to $100,000 and from $100,000 to $250,000) and two rounds of small grants (up to $15,000).

responsive grants aim to encourage new ideas, approaches, and relationships that can help address emerging needs and connect more people to legal information and supports, especially people who are not currently being reached. these grants have provided seed funding for hundreds of innovative initiatives across ontario.

the fy19 defense appropriation provides $6 million (m) to the department of defense multiple sclerosis research program (msrp) to support pioneering concepts and high-impact research that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (ms) to ultimately lessen its personal and societal impact.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate, manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

fy19 msrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website.

applications submitted to the fy19 msrp must address at least one of the following focus areas:

1.            factors that promote central nervous system regenerative potential in demyelination

supports innovative mechanistic studies and translational approaches to promote axonal protection, regeneration, or remyelination in ms and/or relevant experimental models. 

note:  studies addressing the following topics will not be considered for funding: developmental myelination, dysmyelination, blood-brain barrier permeability, basic mechanisms of demyelination, neurodegeneration, or inflammatory mechanisms and anti-inflammatory therapeutic strategies that limit tissue injury secondarily.

2.            correlates of disease activity and progression in ms

supports the identification and/or validation of correlates of disease activity and progression using pre-existing specimens and/or data acquired from well-characterized, adequately controlled, and sufficiently powered patient cohorts.

note:  the study must leverage pre-existing specimens and/or data that are available at the time of application submission; collection of a single set of specimens and/or data collected at one additional time point from participants in the existing cohort is allowed.

3.            biology and measurement of ms symptoms

supports studies on the biology and measurement of ms symptoms, which may include pain, fatigue, depression, anxiety, loss of bladder control, impaired mobility, and cognitive, motor, visual, or sexual dysfunction. 

note:  studies of disease-modifying or regenerative therapies that secondarily impact ms symptoms will not be considered for funding under this focus area.

https://cdmrp.army.mil/funding/msrp

exploration – hypothesis development award - preproposal is due may 21, 2019

independent investigators at or above the level of assistant professor (or equivalent)

*         pre-application submission is required; application submission is by invitation only.

*         supports initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the ms research field.

*         preliminary and/or published data not required.

*         clinical trials are not allowed.

*         anticipated that budgets will not exceed $150,000 in direct costs (plus indirect costs)

*          period of performance not to exceed 2 years.

investigator-initiated research award - preproposal is due may 21, 2019

independent investigators at or above the level of assistant professor (or equivalent)

*         pre-application submission is required; application submission is by invitation only.

*         supports highly rigorous, high-impact research projects that have the potential to make an important contribution to multiple sclerosis (ms) research and/or patient care.

*         preliminary and/or published data are required.

*         clinical trials not allowed.

*         anticipated that budgets will not exceed $600,000 in direct costs (plus indirect costs)

*         period of performance not to exceed 3 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap home page at https://ebrap.org.  for more information about the msrp or other cdmrp-administered programs, please visit the cdmrp website https://cdmrp.army.mil.

point of contact:

cdmrp help desk

301-682-5507

help@ebrap.org

objectives

the cyber security and critical energy infrastructure program (cceip) received $2.42 million over 5 years to enhance the cyber security and resilience of domestic and cross-border energy infrastructure, in support of canada’s national cyber security strategy.

projects

projects funded under the program are intended to strengthen the capability of the energy sector to prevent, prepare, respond to and recover from cyber threats.

activities eligible for support may include:

• research and development: activities that contribute to more secure and resilient domestic and cross-border energy infrastructure, such as studies on interdependencies, supply chain management, and emerging cyber security threats.
• sharing knowledge and expertise: activities that develop and strengthen collective knowledge with respect to addressing cyber threats to domestic and cross-border energy infrastructure, such as workshops, training, and technical briefings.
• standards, best practices and guidelines: activities that advance the development of standards, best practices, and guidelines related to cyber security in the energy sector.

eligible recipients

eligible recipients may include:

• individuals and legal entities validly incorporated or registered in canada, including for-profit and not-for-profit organizations or companies; industry associations; academic institutions; research associations; and, cyber security and critical infrastructure researchers and professionals.
• international recipients, including not-for-profit organizations such as industry associations, agencies, and research associations validly incorporated or registered abroad.
• provincial, territorial, regional and municipal governments and their departments and agencies where applicable.